Epigenetic enzymes, such as DNA methyltransferases and histone deacetylases, modify the expression of genes without altering the DNA sequence. In cancer, the dysregulation of these enzymes can lead to the silencing of tumor suppressor genes and the activation of oncogenes. Epigenetic therapies aim to reverse these aberrant modifications and restore normal gene expression patterns.
